Everything you need to know about GLP-1s for weight loss

View at publisher
Cited by: 0

Abstract

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since. Around 2.5 million people each month accessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of the Digital Clinical Excellence (DiCE) network of primary care digital health providers. Data also show that more than 400,000 items […]

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Bariatric Surgery and Outcomes

Publication details

Journal / source
Pharmaceutical journal/˜The œpharmaceutical journal
Publication date
1 January 2026